The Cigna Group (NYSE:CI) Stock Acquired Rep. Julie Johnson

Representative Julie Johnson (D-Texas) recently bought shares of The Cigna Group (NYSE:CI). In a filing disclosed on April 14th, the Representative disclosed that they had bought between $1,001 and $15,000 in The Cigna Group stock on March 19th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 3/21/2025.
• Sold $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 3/19/2025.
• Sold $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 3/14/2025.
• Sold $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 3/12/2025.
• Purchased $1,001 – $15,000 in shares of 3M (NYSE:MMM) on 3/12/2025.
• Sold $1,001 – $15,000 in shares of Webster Financial (NYSE:WBS) on 3/11/2025.
• Sold $1,001 – $15,000 in shares of Sonos (NASDAQ:SONO) on 3/11/2025.
• Sold $1,001 – $15,000 in shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) on 3/11/2025.
• Sold $1,001 – $15,000 in shares of Teradyne (NASDAQ:TER) on 3/3/2025.
• Sold $1,001 – $15,000 in shares of Zoetis (NYSE:ZTS) on 3/3/2025.

The Cigna Group Stock Performance

Shares of CI traded up $0.57 during mid-day trading on Thursday, hitting $330.01. 608,245 shares of the company’s stock were exchanged, compared to its average volume of 1,682,792. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The business’s 50 day moving average is $314.43 and its two-hundred day moving average is $311.19. The firm has a market capitalization of $90.32 billion, a P/E ratio of 26.95, a P/E/G ratio of 0.98 and a beta of 0.51.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the previous year, the company earned $6.79 earnings per share. On average, equities analysts expect that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th were given a dividend of $1.51 per share. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 1.83%. The ex-dividend date was Wednesday, March 5th. The Cigna Group’s dividend payout ratio (DPR) is presently 49.35%.

Hedge Funds Weigh In On The Cigna Group

A number of institutional investors have recently made changes to their positions in CI. TCTC Holdings LLC purchased a new stake in The Cigna Group during the 4th quarter worth about $25,000. Collier Financial acquired a new stake in The Cigna Group during the fourth quarter worth approximately $32,000. ORG Wealth Partners LLC purchased a new stake in The Cigna Group in the 4th quarter worth approximately $34,000. Putney Financial Group LLC acquired a new position in The Cigna Group in the 4th quarter valued at $36,000. Finally, Compagnie Lombard Odier SCmA purchased a new position in shares of The Cigna Group during the 4th quarter worth $37,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at The Cigna Group

In related news, CEO David Cordani sold 26,527 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the sale, the chief executive officer now directly owns 127,767 shares in the company, valued at approximately $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Elder Granger sold 2,376 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $310.35, for a total transaction of $737,391.60. Following the transaction, the director now directly owns 5,471 shares of the company’s stock, valued at $1,697,924.85. This trade represents a 30.28 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,751 shares of company stock worth $13,603,991 over the last quarter. 0.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on CI shares. Mizuho boosted their price target on shares of The Cigna Group from $360.00 to $384.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Morgan Stanley dropped their target price on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating on the stock in a research report on Friday, January 31st. Oppenheimer cut their target price on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a research note on Friday, January 31st. Sanford C. Bernstein downgraded The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price target on the stock. in a research note on Thursday, February 6th. Finally, Wells Fargo & Company cut their price objective on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 4th. Two analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat, The Cigna Group presently has an average rating of “Buy” and a consensus price target of $373.56.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.